Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 12.85
+0.14 (1.10%)
At close: Sep 30, 2025
Newland Pharmaceutical Revenue
Newland Pharmaceutical had revenue of 139.02M CNY in the quarter ending June 30, 2025, a decrease of -34.48%. This brings the company's revenue in the last twelve months to 688.48M, down -3.58% year-over-year. In the year 2024, Newland Pharmaceutical had annual revenue of 726.44M with 11.51% growth.
Revenue (ttm)
688.48M
Revenue Growth
-3.58%
P/S Ratio
7.32
Revenue / Employee
660.73K
Employees
1,042
Market Cap
5.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 726.44M | 75.00M | 11.51% |
| Dec 31, 2023 | 651.44M | 24.07M | 3.84% |
| Jan 1, 2023 | 627.36M | 113.53M | 22.09% |
| Jan 1, 2022 | 513.84M | 80.71M | 18.64% |
| Dec 31, 2020 | 433.12M | 26.60M | 6.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |